Proteasome inhibitor-I enhances tunicamycin-induced chemosensitization of prostate cancer cells through regulation of NF-κB and CHOP expression

Cellular Signalling

Volumn 23, Issue 5, 2011, Pages 857-865

  Huong, Pham Thi Thu ^a   Moon, Dong Oh ^a   Kim, Sun Ok ^a   Kim, Kyoon Eon ^b   Jeong, Sook Jung ^a   Lee, Ki Won ^a,c   Lee, Kyung Sang ^d   Jang, Jae Hyuk ^a   Erikson, Raymond Leo ^e   Ahn, Jong Seog ^a   Kim, Bo Yeon ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Chungnam National University   (South Korea)

^c Seoul National University   (South Korea)

^d NATIONAL CANCER INSTITUTE   (United States)

^e HARVARD UNIVERSITY   (United States)

Author keywords

CHOP; ER stress; NF B; Proteasome inhibitor 1; Tunicamycin

Indexed keywords

GLUCOSE REGULATED PROTEIN 78; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEASOME INHIBITOR; SMALL INTERFERING RNA; TUNICAMYCIN;

APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE ARREST; CELL PROLIFERATION; CHEMOSENSITIZATION; CONTROLLED STUDY; DRUG POTENTIATION; DRUG TARGETING; ENDOPLASMIC RETICULUM STRESS; HUMAN; HUMAN CELL; INHIBITION KINETICS; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

APOPTOSIS; CELL PROLIFERATION; ENDOPLASMIC RETICULUM; HUMANS; MALE; NF-KAPPA B; OLIGOPEPTIDES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHATIDYLINOSITOL 3-KINASES; PROSTATIC NEOPLASMS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSCRIPTION FACTOR CHOP; TUMOR CELLS, CULTURED; TUNICAMYCIN;

EID: 79951849657     PISSN: 08986568     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellsig.2011.01.010     Document Type: Article

References (30)

1. Alkalay I., Yaron A., Hatzubai A., Orian A., Ciechanover A., Ben-Neriah Y. Proc. Natl Acad. Sci. USA 1995, 92(23):10599.
2. Wang C.Y., Mayo M.W., Baldwin A.S. Science 1996, 274(5288):784.
3. Arlt A., Vorndamm J., Breitenbroich M., Folsch U.R., Kalthoff H., Schmidt W.E., Schafer H. Oncogene 2001, 20(7):859.
4. Dantzig A.H., de Alwis D.P., Burgess M. Adv. Drug Deliv. Rev. 2003, 55(1):133.
5. Ostrowska H. Cell. Mol. Biol. Lett. 2008, 13(3):353.
6. Orlowski R.Z., Kuhn D.J. Clin. Cancer Res. 2008, 14(6):1649.
7. Elbein A.D. Annu. Rev. Biochem. 1987, 56:497.
8. Kramer R., Weber T.K., Arceci R., Ramchurren N., Kastrinakis W.V., Steele G., Summerhayes I.C. Br. J. Cancer 1995, 71(4):670.
9. Wang G., Yang Z.Q., Zhang K. Am. J. Transl. Res. 2010, 2(1):65.
10. Bedard K., MacDonald N., Collins J., Cribb A. Basic Clin. Pharmacol. Toxicol. 2004, 94(3):124.
11. Hacki J., Egger L., Monney L., Conus S., Rosse T., Fellay I., Borner C. Oncogene 2000, 19(19):2286.
12. Marciniak S.J., Yun C.Y., Oyadomari S., Novoa I., Zhang Y., Jungreis R., Nagata K., Harding H.P., Ron D. Genes Dev. 2004, 18(24):3066.
13. Rasheva V.I., Domingos P.M. Apoptosis 2009, 14(8):996.
14. Yang W., Monroe J., Zhang Y., George D., Bremer E., Li H. Cancer Lett. 2006, 243(2):217.
15. Liu W., Kato M., Itoigawa M., Murakami H., Yajima M., Wu J., Ishikawa N., Nakashima I. J. Cell. Biochem. 2001, 83(2):271.
16. Li Y., Schwabe R.F., DeVries-Seimon T., Yao P.M., Gerbod-Giannone M.C., Tall A.R., Davis R.J., Flavell R., Brenner D.A., Tabas I. J. Biol. Chem. 2005, 280(23):21763.
17. Pan K., Wang H., Liu W.L., Zhang H.K., Zhou J., Li J.J., Weng D.S., Huang W., Sun J.C., Liang X.T., Xia J.C. Immunobiology 2009, 214(5):350.
18. Nakagawa T., Zhu H., Morishima N., Li E., Xu J., Yankner B.A., Yuan J. Nature 2000, 403(6765):98.
19. Morishima N., Nakanishi K., Takenouchi H., Shibata T., Yasuhiko Y. J. Biol. Chem. 2002, 277(37):34287.
20. Li L., Ittmann M.M., Ayala G., Tsai M.J., Amato R.J., Wheeler T.M., Miles B.J., Kadmon D., Thompson T.C. Prostate Cancer Prostatic Dis. 2005, 8(2):108.
21. Arlt A., Gehrz A., Muerkoster S., Vorndamm J., Kruse M.L., Folsch U.R., Schafer H. Oncogene 2003, 22(21):3243.
22. Janssen Y.M., Sen C.K. Meth. Enzymol. 1999, 300:363.
23. Shi Y.Y., Small G.W., Orlowski R.Z. Breast Cancer Res. Treat. 2006, 100(1):33.
24. Pahl H.L., Baeuerle P.A. EMBO J. 1995, 14(11):2580.
25. Zou C.G., Cao X.Z., Zhao Y.S., Gao S.Y., Li S.D., Liu X.Y., Zhang Y., Zhang K.Q. Endocrinology 2009, 150(1):277.
26. Nozaki S., Sledge G.W., Nakshatri H. Oncogene 2001, 20(17):2178.
27. Adams J., Palombella V.J., Sausville E.A., Johnson J., Destree A., Lazarus D.D., Maas J., Pien C.S., Prakash S., Elliott P.J. Cancer Res. 1999, 59(11):2615.
28. Karin M., Ben-Neriah Y. Annu. Rev. Immunol. 2000, 18:621.
29. Wang X.Z., Lawson B., Brewer J.W., Zinszner H., Sanjay A., Mi L.J., Boorstein R., Kreibich G., Hendershot L.M., Ron D. Mol. Cell. Biol. 1996, 16(8):4273.
30. Zinszner H., Kuroda M., Wang X., Batchvarova N., Lightfoot R.T., Remotti H., Stevens J.L., Ron D. Genes Dev. 1998, 12(7):982.